Ulcerative Proctitis/Ulcerative Proctosigmoiditis - Houston TX (Clinical Trial # 12091)
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials. 
| City: |
|
Houston |
| State: |
|
TX |
| Zip Code: |
|
77079 |
| Study summary: |
|
A phase 3, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of Budesonide Foam (2MG/25ML BID for 2 weeks, followed by 2MG/25ML QD for 4 weeks)versus placebo in subjects with active mild to moderate ulcerative proctitis or proctosigmoiditis. |
| Qualified participants must: |
|
• Be 18-75 years of age
•
Have diagnosis of active UP/UPS with mild to moderate symptoms
•
Be able to complete all 8 scheduled visits within approximately 11 weeks
|
| Participants may receive: |
|
Study medication at no cost and reimbursement for time and travel may be provided. |
|
|
|
| Clinic Profile: |
|
View Clinic Profile |
|
Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.